Take the challenge; learn the dynamics of business.
Make a real and immediate impact in the pharmaceutical industry and your organisation by applying leading edge tools, and the latest management and leadership thinking.
Ranked 1st in Europe and 3rd in the world*, the Executive MBA at London Business School inspires global business leaders to think critically, plan strategically and act decisively in an interdependent and complex global economy.
Taught by the world's top faculty, you'll gain the analytical skills, understanding and confidence in business language to influence strategy and gain valuable business insights to the dynamics of the pharmaceutical industry.
The diversity of students in terms of nationalities, industries and cultures not only broadens your perspective and enhances class debate, but also provides you access to an extensive and international network of professionals. This powerful combination can be applied to crafting the success of your organisation and future career.
Studying on alternate Fridays and Saturdays enables you to pursue your studies without interrupting your career momentum. We offer an extensive range of elective courses to meet your areas of interest and specialisation. The International Assignments are specifically designed so you can effectively manage and communicate across boundaries.
Accelerate your career today with the Executive MBA. To speak to our current students and alumni, and experience a taste of our world-class faculty come to our next information sessions on Tuesday 20th June and Tuesday 18 July. Or look online at http://www.london.edu/epe
*Financial Times survey, 2005
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Amgen’s Imdelltra Demonstrates Significant Overall Survival Improvement in Small Cell Lung Cancer
April 16th 2025In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered Imdelltra achieved a statistically significant and clinically meaningful improvement in overall survival compared to standard-of-care chemotherapy.